Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | CA9 | Q16790 | 5/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | CHAT | P28329 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.47 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.47 |
| ▸ | HPGDS | O60760 | 1/20 | 0.46 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2200140 | 1.00 | CA12 (0.54) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL11879462 | 0.99 | CA12 (0.53) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL1536252 | 0.99 | CA12 (0.53) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL1536256 | 0.99 | CA12 (0.56) | CA12CA1CA2CA9MEN1 | |
| Potassium SCHEMBL2203007 | 0.99 | CA12 (0.53) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL2222015 | 0.98 | CA12 (0.52) | CA12CA1CA2CA9MEN1 | |
| Potassium SCHEMBL2203859 | 0.98 | CA12 (0.55) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL15893991 | 0.95 | CA12 (0.50) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL17550070 | 0.95 | CA12 (0.50) | CA12CA1CA2CA9MEN1 | |
| SCHEMBL17550065 | 0.94 | CA12 (0.52) | CA12CA1CA2CA9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10383960-B2 | Small molecule imaging of fungi by positron emission tomography scanning | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2019-08-20 | — | — | US | disclosed |
| US-9968693-B2 | Small molecule imaging of fungi by positron emission tomography scanning | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2018-05-15 | — | — | US | disclosed |
| US-9487503-B2 | Stilbene optical brighteners | 3V SIGMA S.P.A. (IT) | 2016-11-08 | — | — | US | disclosed |
| US-20160287729-A1 | SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2016-10-06 | — | — | US | disclosed |
| US-9376405-B2 | Bis-(triazinylamino)-stilbene derivatives | CLARIANT INTERNATIONAL LTD (CH) | 2016-06-28 | — | — | US | disclosed |
| EP-2933253-A1 | STILBENE OPTICAL BRIGHTENERS | 3V SIGMA S.p.A (IT) | 2015-10-21 | — | — | EP | disclosed |
| US-9089134-B2 | Targeting delivery of anti-fungal agents | EDH BIOTECH CORP (US) | 2015-07-28 | — | — | US | disclosed |
| US-9089134-B2 | Targeting delivery of anti-fungal agents | EDH BIOTECH CORP (US) | 2015-07-28 | — | — | US | disclosed |
| US-20150037396-A1 | Targeted Delivery of Anti-Fungal Agents | EDH BIOTECH CORP | 2015-02-05 | — | — | US | disclosed |
| US-20150037396-A1 | Targeted Delivery of Anti-Fungal Agents | EDH BIOTECH CORP | 2015-02-05 | — | — | US | disclosed |
| US-20140203212-A1 | FLUORESCENT WHITENING AGENT AQUEOUS SOLUTIONS | 3V SIGMA S.P.A (IT) | 2014-07-24 | — | — | US | disclosed |
| US-20140142305-A1 | NOVEL BIS-(TRIAZINYLAMINO)-STILBENE DERIVATIVES | CLARIANT INTERNATIONAL LTD (CH) | 2014-05-22 | — | — | US | disclosed |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-10-23 | — | — | US | disclosed |
| EP-1237536-B1 | THE USE OF FLUORESCENT WHITENING AGENTS | CIBA SC HOLDING AG (CH) | 2007-11-14 | — | — | EP | disclosed |
| US-20070260060-A1 | Amphoteric fluorescent whitening agents | SCHEFFLER GOETZ | 2007-11-08 | — | — | US | disclosed |
| US-7247174-B2 | Amphoteric fluorescent whitening agents | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-07-24 | — | — | US | disclosed |
| US-7198731-B2 | Optical brighteners | CLARIANT FINANCE (BVI) LIMITED (VG) | 2007-04-03 | — | — | US | disclosed |
| US-4092243-A | CONTAINING TRIAZINE RINGS, SELECTIVE ABSORPTION OF HYDROCARBONS | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-30 | — | — | US | disclosed |
| US-4005026-A | Detergent compositions containing novel crystalline forms of optical brighteners | STERLING DRUG INC. (US) | 1977-01-25 | — | — | US | disclosed |
| US-3957728-A | MODIFIED WITH S-TRIAZINES; ABSORBENTS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070260060-A1 | Amphoteric fluorescent whitening agents | NCL, NCSTN, APLNR | CA12 142/4885CA1 392/4885CA2 251/4885 |
| US-20150037396-A1 | Targeted Delivery of Anti-Fungal Agents | ALG1, MANBA, ERG28 | CA12 328/4885CA1 2108/4885CA2 1023/4885 |
| US-20160287729-A1 | SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING | NAT1, ARSA, TST | CA12 219/4885CA1 175/4885CA2 229/4885 |
| US-20140203212-A1 | FLUORESCENT WHITENING AGENT AQUEOUS SOLUTIONS | TYR, ALK, MAP7 | CA12 3421/4885CA1 4437/4885CA2 3345/4885 |
| US-20140142305-A1 | NOVEL BIS-(TRIAZINYLAMINO)-STILBENE DERIVATIVES | TSN, SMARCB1, TXLNA | CA12 3610/4885CA1 4714/4885CA2 4354/4885 |
| US-10383960-B2 | Small molecule imaging of fungi by positron emission tomography scanning | NAT1, ARSA, TST | CA12 218/4885CA1 172/4885CA2 223/4885 |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | CA12 4027/4885CA1 4302/4885CA2 1991/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.